Metabolic Syndrome in Adults Receiving Clozapine; The Need for Pharmacist Support

People who are diagnosed with treatment resistant schizophrenia (TRS) are likely to have clozapine as a therapeutic management option. There is a high prevalence of metabolic syndrome in patients receiving clozapine. To mitigate against this, monitoring of weight, waist circumference, lipid profile,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurley, Kathleen, O’Brien, Sinead, Halleran, Ciaran, Byrne, Derina, Foley, Erin, Cunningham, Jessica, Hoctor, Fionnuala, Sahm, Laura J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964454/
https://www.ncbi.nlm.nih.gov/pubmed/36827661
http://dx.doi.org/10.3390/pharmacy11010023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964454/
https://www.ncbi.nlm.nih.gov/pubmed/36827661
http://dx.doi.org/10.3390/pharmacy11010023

Ejemplares similares